OrthoAccel Obtains $10,000,000 New Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    6575 West Loop South Bellaire, TX 77401
  • Company Description
    The AcceleDent System is currently in a randomized controlled clinical trial at the University of Texas Health Science Center in San Antonio. This trial was enrolled under an Investigational Device Exemption. FDA will be reviewing the AcceleDent System, which is regulated as a medical device. If clearance is granted, the product will be available at an orthodontist near you.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    The Company will formally launch the AcceleDent system in May at the American Association of Orthodontists annual conference in Honolulu, HI.
  • M&A Terms
  • Venture Investor
    HealthpointCapital Partners
  • Venture Investor
    S3 Ventures

Trending on Xconomy